Cases
Representative Matters: Represented Lovett Commercial, a Houston-based commercial real estate developer, in the closing of Phase 2 of financing which consisted of $11.8 million in New Markets Tax Credit financing, a $25 million bridge loan from Cedar Rapids Bank & Trust,
a $40 million opportunity fund investment for the $150 million historic renovation of the former Houston Post Office Building, a mixed-use development to house a music venue, retail spaces
rooftop urban farm.
Assisted the client in a complete overhaul of the entity structuring for this hotelier client
positioned the client for a private equity offering.
Represented a foreign family office in a $5 million Series C investment in a US-based leading global provider of parcel delivery software
hardware to businesses in the U.S.
Europe.
Assisted client with preparation of the corporate governance documents necessary to secure educational accreditation, design
implementation of necessary internal procedures to avoid conflict of interest, self-dealing
excess benefit transactions
preparation
prosecution of the client's Application for Recognition of Exemption under IRC 501(c)(3).
Assisted the client with removal of a high level executive who was also a significant shareholder in the company, involving a prolonged
contentious negotiation over the value of the stock for buy out purposes, requiring detailed
complex analysis.
Advised concerning year-end multi-country corporate restructuring for South American investors of $72 million in real estate
other assets, which were located in six jurisdictions (France, Panama, Peru, Massachusetts, Florida
Colorado)
transferred to a new holding company.
Represented Voxx International Corporation in its $20 million acquisition, through Newco, a Delaware LLC, of 54 percent of the assets of EyeLock, Inc., a Puerto Rico corporation,
EyeLock Corporation, a Delaware corporation,
a wholly-owned subsidiary of EyeLock, Inc.
Represented Quest Diagnostics in the sale of a stream of royalty revenue from commercialization of the drug c
idate Ibrutinib to Royalty Pharma for $485 million in cash.
Coordinated a multi-state transfer tax analysis in connection with the acquisition of an extensive real estate portfolio, including related transaction structuring.
Represented a client in the formation of a $450 million real estate investment fund.
Represented a client in the acquisition of a $600 million real estate portfolio.
Represented a client with respect to structuring a $75 million gift to fund capital improvements for a nonprofit.